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Bacterial biofilms are involved in amultitude of serious chronic infections. In recent years, modeling of biofilm
infection in vitro has led to the identification of microbial determinants that govern biofilm development.
However, we lack information as to whether the biofilm formation mechanisms identified in vitro have
relevance for biofilm-associated infection. Here, we discuss the molecular basis of biofilm formation. Staph-
ylococci and Pseudomonas aeruginosa are used to illustrate key points because their biofilm development
process has been well studied. We focus on in vivo findings, such as obtained in animal infection models,
and critically evaluate the in vivo relevance of in vitro findings. Although conflicting results about the role
of quorum sensing in biofilm formation have been obtained, we argue that integration of in vitro and in vivo
studies allows a differentiated view of this mechanism as it relates to biofilm infection.Recognizing that laboratory conditions poorly represent micro-
bial life in nature, William J. Costerton coined the term ‘‘biofilm’’
in 1978 to describe surface-attached microbial agglomerations
(Costerton et al., 1978). Since that early realization, biofilm
research has grown into a recognized field of study within micro-
biology. Notably, biofilms play an immensely important role in
human health, as they shelter bacteria from antibiotics and
host defense during infection (Costerton et al., 1999). The
percentage of bacterial infections that involve biofilms varies de-
pending on the reporting agency, with estimates of 65% of all
infections according to the Centers for Disease Control and 80%
according to the National Institutes of Health. Sources of infec-
tion include commensal microbes that live on human body
surfaces, such as staphylococci, and originally environmental
microbes, such as Pseudomonas aeruginosa.
In the last three decades, investigators have developed
multiple ways to investigate biofilms using in vitro models
(McBain, 2009). Ranging from simple attachment tests in micro-
titer plates to sophisticated biofilm reactors, and from qualita-
tive microscopic examination to elaborated mathematical
evaluation of images acquired by confocal laser-scanning
microscopy (CLSM), these in vitro models have provided
detailed insights into the processes that lead to the formation
of biofilms. In particular, the combination of these approaches
with molecular biology techniques has produced important
information related to the genetic requirements of biofilm devel-
opment. Procedures such as transposon mutagenesis and
genome-wide screening led to the identification of genes
involved in the production of biofilm matrix components and
the regulatory principles that govern biofilm development
(Friedman and Kolter, 2004a; Heilmann et al., 1996; Simm
et al., 2004). Cloning of biofilm determinants and the production
of isogenic deletion mutants subsequently enabled investiga-
tors to further decipher the precise roles of these genes in
biofilm formation.
However, biofilms are very complex communities that interact
with the human body in a multitude of ways that are hard toChemistry & Biology 1mimic using in vitro setups. Unfortunately, although in vitro bio-
film studies have greatly advanced our understanding of biofilm
development, in vivo investigation of the molecular processes
that occur during biofilm-associated human disease has trailed
behind.
Among the bacteria that are involved in biofilm-associated
infections, the Gram-negative bacterium P. aeruginosa has
received the most attention. This organism is particularly noto-
rious for causing severe chronic infection in patients with cystic
fibrosis (CF) (Høiby et al., 2010). However, adequate animal
models of biofilm-associated infection in CF have not been avail-
able until recently. Although the physiology and especially the
gene regulatory processes of P. aeruginosa have been well
studied, the in vivo relevance of these processes for the most
part remains to be established.
The Gram-positive bacteria Staphylococcus aureus and
S. epidermidis are the most frequent causes of nosocomial
infections on indwelling medical devices (Otto, 2008). Because
device-related infections occur extremely frequently and are
commonly associated with biofilms, these bacteria can be re-
garded as the most important etiological agents of biofilm-
associated infections. Staphylococci are difficult to manipulate
on a genetic level, although considerable advances have
recently been made in this field. On the other hand, it is easier
to model device-related infections than CF in animals.
Biofilm research is also being performed in many other micro-
organisms, such as Escherichia and Vibrio ssp. (Beloin et al.,
2008; Yildiz and Visick, 2009). However, given thewealth of infor-
mation available in particular for P. aeruginosa and staphylo-
cocci, we chose to focus on these organisms in this work. First,
we outline the mechanisms of biofilm development, focusing on
general principles rather than species-specific peculiarities. We
then provide a critical assessment of whether in vitro findings
bear on the in vivo situation, or whether the in vivo significance
of biofilm mechanisms was established using animal infection
models. Finally, we evaluate possible avenues for the develop-
ment of antibiofilm drugs.9, December 21, 2012 ª2012 Elsevier Ltd All rights reserved 1503
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As they proceed, most bacterial infections involve biofilms, but
there are some examples of biofilm-associated infections in
which the contribution of biofilms is particularly characteristic
and important. These include infections on indwelling medical
devices such as intravascular catheters, prosthetic vascular
grafts, cardiac devices, prosthetic joints, and shunts. Coagu-
lase-negative staphylococci, mainly S. epidermidis, are the
most frequent causes of these types of infections (Rogers
et al., 2009). In addition to the strong biofilm-forming capacity
of many S. epidermidis strains, the sheer abundance of
S. epidermidis on human skin may explain its frequent involve-
ment in device-related biofilm infection (Otto, 2009).
Biofilm infections may also develop independently of
indwelling medical devices, e.g., in native valve endocarditis,
open wounds, or dental plaque. Although they are not as
frequent as many other biofilm-associated infections, biofilms
in patients with chronic CF have received much attention owing
to the high morbidity associated with the disease. For a long
time, CF has been in the center of medical-biofilm research,
and therefore much of what we know about biofilms was first
investigated in the main CF pathogen, P. aeruginosa. Of
note, the lungs of CF patients are not infected solely by
P. aeruginosa; however, in chronic CF infections, this bacterium
tends to outcompete other bacteria that infect CF patients in
earlier stages of the disease, such as Burkholderia cepacia and
S. aureus (Rajan and Saiman, 2002). This phenomenon appears
to be specific for CF infections, as P. aeruginosa does not
outcompete other biofilm bacteria in other infections, such as
chronic wounds (Kirketerp-Møller et al., 2008).
In Vivo Biofilm Models
Investigators have modeled indwelling device-related infection
using a series of different approaches and animals. The easiest
and most frequently used model includes the placement of
a piece of catheter or other plastic tubing under the skin of
a mouse at the dorsum (Kadurugamuwa et al., 2003; Rupp
et al., 1999a). Often, biofilms are established on the tubing before
insertion, which has the advantage of enabling reproducibility, in
contrast to the alternative method of injecting bacteria into the
lumen of already inserted tubing. This model is supposed to
mimic biofilms that originate from contaminated catheters quite
closely; however, like many other animal models, it suffers from
the fact that the inocula used greatly exceed the number of
bacteria from which such an infection is supposed to start in
a real-life scenario. In models of device-related endocarditis,
the inocula are smaller and biofilm infection may actually
progress, but these models are surgically more challenging
and require larger animals such as rats or rabbits (Hirano
and Bayer, 1991; Xiong et al., 2005). Tissue cage models,
which were first established in guinea pigs but are also often
performed in mice, use little, hollow, ball-like cages in which
catheter tubing is placed and assayed for biofilm development
(Zimmerli et al., 1982).
Biofilm-associated wound infection is difficult to mimic,
because the skin of commonly used test animal species is inher-
ently different from human skin. Pig-skin infection appears to
come as close as possible to human-skin infection (Roche
et al., 2012), but pigs are not available as test animals for most1504 Chemistry & Biology 19, December 21, 2012 ª2012 Elsevier Ltdresearchers. Similarly, dental plaque formation is extremely
difficult to simulate.
Because P. aeruginosa has been the key subject of biofilm
studies, biofilm researchers have tried for a long time to establish
an animal model of CF biofilm-associated lung infection. Earlier
models have been criticized as not being representative of
chronic infection, for two main reasons (Hoffmann, 2007): first,
the most commonly used P. aeruginosa strain, PAO1, is a non-
mucoid isolate that causes acute types of infection that are not
representative of the clinical situation in chronic infection;
second, the bacteria were embedded in an artificial biofilm
(e.g., made of agar) to prevent mechanical clearing. However,
a model that uses a clinical isolate without the need for artificial
embedding was recently established (Hoffmann et al., 2005).
Establishing a Biofilm Infection: Attachment
Biofilm formation is commonly considered to occur in three main
stages: (1) attachment to a surface; (2) proliferation and forma-
tion of the characteristic, mature biofilm structure; and (3)
detachment, which is also often called dispersal (O’Toole
et al., 2000). Recent research has provided molecular insight
into all three stages (Figure 1).
Many studies have investigated the attachment of biofilm-
forming bacteria to abiotic surfaces. In general, the bacterial
characteristics that determine the degree of attachment to
such surfaces have a physicochemical nature. Most notable of
these is hydrophobicity, which is determined by the overall
composition of the bacterial surface. Some specific determi-
nants of attachment have been reported; however, it needs to
be stressed that the techniques used to investigate attachment
determinants are often simple and similar to those employed
for the investigation of biofilm formation overall. Consequently,
there is a significant overlap between factors that have been re-
ported to be involved in the attachment and proliferative stages
of biofilm development. For example, in S. aureus and
S. epidermidis, teichoic acids and the surface protein autolysin
were linked to abiotic surface attachment (Gross et al., 2001;
Heilmann et al., 1997), but it can be assumed that their impact
is indirect, via alteration of surface hydrophobicity. The
S. epidermidis autolysin AtlE was shown to have a role in
device-related infection (Rupp et al., 2001), but it is difficult to
judge whether the detected effect was due to attachment or
the primary role of AtlE in cell growth and division. In
P. aeruginosa, flagella (O’Toole and Kolter, 1998), pili (De´ziel
et al., 2001), fimbria (Vallet et al., 2001), extracellular DNA
(eDNA) (Whitchurch et al., 2002), and the Psl exopolysaccharide
(Ma et al., 2009) were attributed functions in surface attachment.
Several of these factors work by facilitating the transport of
P. aeruginosa to surfaces where it can form a biofilm, reflecting
the fact thatP. aeruginosa is motile (in contrast to staphylococci).
However, it is certainly debatable whether the requirement for
motility to reach a surface represents an attachment phenom-
enon in the strictest sense. Psl and eDNA also were reported
to affect biofilm formation in later stages; a specific role for these
factors in attachment is thus questionable for the reasons
outlined above.
Biofilm attachment to abiotic surfaces may play an important
role when biofilms persist in the hospital setting (e.g., on medical
instruments and doorknobs) as fomites of infection. However,All rights reserved
Figure 1. Phases of In Vivo Biofilm
Development
Biofilms develop via initial attachment, which
depends on transport of the bacteria to a surface
that is passive in the case of nonmotile bacteria
such as staphylococci (yellow), and active in
the case of motile bacteria such as P. aeruginosa
(red). Attachment itself is governed by specific
protein–protein interactions of the bacterial
surfacewith humanmatrix proteins. Attachment to
an abiotic surface such as a catheter depends on
bacterial surface hydrophobicity, but this mecha-
nism is believed to have minor importance in vivo.
Subsequent steps do not differ in principle
between motile and nonmotile bacteria. They
involve proliferation, embedding in an extracellular
matrix, and maturation. The latter depends on
cell–cell disruptive factors, recently identified to be
primarily surfactants. Strong production of
surfactants, which are controlled by QS, leads to
biofilm detachment (dispersal). In the case of
motile bacteria, upregulation of motility, starting in
the center of the biofilm mushroom caps, assists
dispersal.
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importance for biofilm formation in vivo. Attachment to tissue
or medical devices in the human body is mainly governed by
the interaction of bacteria with human matrix proteins, which
effectively cover devices soon after insertion. In staphylococci,
the major underlying molecules are a class of surface-attached
bacterial proteins termed microbial surface components recog-
nizing adhesive matrix molecules (MSCRAMMs; Clarke and
Foster, 2006; Foster and Ho¨o¨k, 1998). Many MSCRAMMS
have been shown to have a role in staphylococcal infection or
colonization in vivo. These include fibronectin-binding (McElroy
et al., 2002) and fibrinogen-binding (Josefsson et al., 2001)
proteins, and the S. aureus surface protein SasX, which was
linked to an ongoing outbreak of methicillin-resistant S. aureus
(Li et al., 2012). Furthermore, MSCRAMMs were shown in
multiple in vitro assays to promote adhesion to human matrix
proteins such as fibrinogen (Pei et al., 1999), fibronectin (Maxe
et al., 1986), and others. In the case of P. aeruginosa, indications
for a role in attachment of specific determinants during infection
have been exclusively derived from in vitro experiments, often
using only abiotic surfaces. Therefore, confirmation that specific
P. aeruginosa attachment factors play a role during infection has
to await detailed in vivo investigation.
Formation of a Biofilm: Matrix Formation
After attachment to tissue or matrix-covered devices is accom-
plished, infectious bacterial biofilms grow by proliferation and
production of an extracellular matrix. The function of the matrix
is to provide adhesion between bacterial cells, thereby enabling
the formation of amultilayered biofilm. In vitro evidence indicates
that the biofilm matrix consists of a multitude of components of
different chemical natures, including exopolysaccharides, pro-
teins, eDNA, and other polymers. These components may also
facilitate the formation of bacterial agglomerations that do not
necessarily constitute a biofilm, and provide protection fromChemistry & Biology 1antibiotics and host defenses independently of biofilm formation
(Mai et al., 1993; Vuong et al., 2004c).
S. aureus and S. epidermidis produce an exopolysaccharide
named polysaccharide intercellular adhesin (PIA, also called
poly-N-acetyl glucosamine [PNAG]; Cramton et al., 1999;
Mack et al., 1996; Maira-Litra´n et al., 2002; Figure 2). PIA/
PNAG is probably the most important component of the extra-
cellular matrix in staphylococci, although there is evidence that
in vitro and in vivo staphylococcal biofilms can form without
PIA/PNAG (Rohde et al., 2007). In such cases, other matrix
components substitute for the missing exopolysaccharide. An
important feature of the PIA/PNAG molecule is its partial deace-
tylation, which produces positively charged residues that likely
have an important role in interacting with other, negatively
charged matrix components, resulting in a tightly connected
matrix network (Vuong et al., 2004a). The importance of PIA/
PNAG in biofilm-associated infection was demonstrated in
several animal infection models (Begun et al., 2007; Kropec
et al., 2005; Rupp et al., 1999a, 1999b; Vuong et al., 2004a).
Importantly, PIA/PNAG is also found in other biofilm-forming
bacteria, includingmany staphylococci and even Gram-negative
bacteria (Kaplan et al., 2004; Wang et al., 2004).
Teichoic acids are characteristic major components of the cell
surface in Gram-positive bacteria (Glaser, 1973). Teichoic acids
are negatively charged and have been shown to contribute to
biofilm formation in staphylococci. Most likely, they interact
with other surface polymers and function as a scaffold for protein
attachment (Gross et al., 2001; Sadovskaya et al., 2005).
P. aeruginosa produces three exopolysaccharides: the
glucose-rich Pel polysaccharide (Friedman and Kolter, 2004b),
the mannose-rich Psl polysaccharide (Friedman and Kolter,
2004b), and alginate (Evans and Linker, 1973; Govan and De-
retic, 1996; Høiby, 1974). Alginate is an acylated polysaccharide
composed of guluronic acid (GulUA) and mannuronic acid
(ManUA)monomers (Figure 2). A wealth of studies have provided9, December 21, 2012 ª2012 Elsevier Ltd All rights reserved 1505
Figure 2. Biofilm Exopolysaccharides in P. aeruginosa and
Staphylococci
The major biofilm exopolysaccharide of staphylococci (and some other
bacteria) is PIA (or PNAG), a homopolymer of beta-1,6-linked GlcNAc resi-
dues, and approximately one fourth of these residues become deacetylated
after export. Deacetylation creates free amino groups that at neutral or acid pH
give the molecule a cationic character (shown in blue). Major exopoly-
saccharides of P. aeruginosa are the ManUA/GulUA-based, negatively
charged alginate (negative charges, red) and the mannose-rich neutral Psl.
Manp, mannopyranose; Rhap; rhamnopyranose; Glcp, glucopyranose.
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tion of these polysaccharides. For example, production was
reported to be regulated in a way opposite to that observed for
factors involved in acute infection (Goodman et al., 2009). Impor-
tantly, alginate is overproduced during the establishment of
a chronic CF infection, resulting in what is called a mucoid
phenotype (Evans and Linker, 1973). The role of these biofilm
polysaccharides in CF has not yet been addressed using defined
genetic mutants and animal infection models, despite early
discovery of the genes involved in alginate biosynthesis (Deretic
et al., 1987; Goldberg andOhman, 1984). However, it was shown
that alginate biosynthesis contributes to virulence in acute forms
of P. aeruginosa infection (Goldberg et al., 1995).1506 Chemistry & Biology 19, December 21, 2012 ª2012 Elsevier LtdProteins may have an accessory or a primary (e.g., in the
absence of staphylococcal PIA) role in formation of the biofilm
matrix (Rohde et al., 2007). In S. epidermidis, a protein called
accumulation-associated protein (Aap) contributes to the estab-
lishment of intercellular connections by forming fibrils on the cell
surface (Banner et al., 2007; Hussain et al., 1997; Rohde et al.,
2005). In S. aureus and S. epidermidis, additional surface
proteins such as protein A, the S. aureus surface proteins
SasC and SasG, extracellular matrix binding protein (Embp), bio-
film-associated protein (Bap), and the fibronectin-binding
proteins FnbpA and FnbpB were implicated in matrix formation
(Christner et al., 2010; Corrigan et al., 2007; Cucarella et al.,
2001; Merino et al., 2009; O’Neill et al., 2008; Schroeder et al.,
2009). Recent data indicate that in vitro biofilm formation of
S. aureus as a species, in particular among methicillin-resistant
strains, may rely more on eDNA and proteins, whereas PIA/
PNAG may play a more important role in S. epidermidis and
methicillin-susceptible S. aureus (Izano et al., 2008; O’Neill
et al., 2007; Pozzi et al., 2012). An in vivo role of several staphy-
lococcal proteinaceous biofilm factors was established in animal
infection models (Cucarella et al., 2001; Shinji et al., 2011).
However, in many cases it is unclear whether the observed
effects are due to a contribution to biofilm development, tissue
attachment, or biofilm-independent immune evasion mecha-
nisms. Recent findings in P. aeruginosa indicate that a protein
called CdrA is involved in exopolysaccharide cross-linking
(Borlee et al., 2010); however, as yet, there is no in vivo evidence
for a role of proteinaceous matrix components in P. aeruginosa
CF infection.
In recent years, it was found that eDNA, which is released from
dying cells, is a component of the extracellular biofilm matrix
(Whitchurch et al., 2002). DNA is a polyanionic molecule that is
believed to interact with other matrix polymers of opposite
charge, thereby contributing to the matrix network in a way
similar to that observed for other polymers with distinct charge
properties. In many biofilm-forming organisms, eDNA has an
analogous effect (Rice et al., 2007; Thomas et al., 2008; Whitch-
urch et al., 2002). Whether eDNA has a role in biofilm-associated
infection is difficult to assess. Arguing against an in vivo role of
bacterial eDNA is the presence of the potent DNase I in human
serum, which (at least in vitro) has been shown to degrade bacte-
rial biofilms that contain eDNA as a key matrix constituent (Ka-
plan et al., 2012; Whitchurch et al., 2002).
Formation of a Structured Biofilm and Dispersal
Mechanism: Quorum Sensing and Surfactants
When grown in vitro, mature biofilms have a characteristic mush-
room-like structure that contains channels that are believed to
be essential for providing nutrients to cells in deeper biofilm
layers (O’Toole et al., 2000). This indicates that in addition to
the well-studied adhesive matrix components that mediate
aggregation, biofilm maturation requires cell–cell disruptive
factors. In the outmost layers of a biofilm or upon strong expres-
sion, such disruptive factors also cause cell detachment or
dispersal.
Quorum sensing (QS), a phenomenon in which increased cell
density triggers changes in gene expression, has received
much attention as a regulator of biofilm formation and matura-
tion. In staphylococci, QS is established by the accessoryAll rights reserved
Figure 3. QS in Staphylococci
QS in staphylococci is exerted by the agr locus,
which contains the agrA, agrC, agrD, and agrB
genes (RNAII transcript) and RNAIII, the intracel-
lular effector of the system, which also contains
the hld gene for the PSM d-toxin. AgrD is a pre-
pheromone that is exported andmodified by AgrB,
resulting in a characteristic thiolactone-containing
autoinducing peptide (AIP). Activation of the AgrC/
AgrA two-component system by AIP binding leads
to transcription of RNAIII and RNAII, with the latter
leading to autofeedback and fast upregulation
of agr and agr target expression at a certain
threshold of cell density. Agr-regulated, biofilm-
relevant genes are first and foremost PSMs, which
are regulated by direct binding of AgrA to their
promoters, rather than via RNAIII. In contrast,
many MSCRAMMs are negatively regulated by
RNAIII, indicating that tissue attachment is
a mechanism that is no longer needed during later
stages of infection.
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translationally modified peptide that interacts with a two-compo-
nent system in an autofeedback loop, ultimately resulting in
a considerable shift in gene expression patterns during the early
stationary growth phase (Ji et al., 1995; Recsei et al., 1986;
Figure 3). In general, Agr upregulates toxins and other acute viru-
lence factors, and downregulates surface proteins such as
MSCRAMMs. QS in P. aeruginosa is more complicated and
comprises three systems that are interconnected in hierarchical
order and together govern the expression of hundreds of genes
(Schuster et al., 2003; Figure 4). The Las system senses 3-oxo-
C12-homoserine lactone, the Rhl system senses C4-homoserine
lactone, and the Pqs system senses a specific quinolone referred
to as Pseudomonas quinolone signal (PQS; Juhas et al., 2005).
Recent reports have provided important insights into the QS-
controlled factors that structure biofilms and cause detachment.
In both P. aeruginosa and staphylococci, these are surfactants
that are believed to function via the disruption of noncovalent
interactions between biofilm cells and matrix molecules. The
surfactant molecules responsible for biofilmmaturation in staph-
ylococci are phenol-soluble modulins (PSMs), which are amphi-
pathic, a-helical peptides that are controlled by the Agr QS
system in an exceptionally direct manner (Periasamy et al.,
2012; Queck et al., 2008; Wang et al., 2011). In P. aeruginosa,
the QS-controlled surfactants are amphipathic glycolipids called
rhamnolipids (Boles et al., 2005; Davey et al., 2003). Rhamnolipid
synthesis is induced in the center of the mushroom cap, which is
consistent with it being subject to cell-density control (Lequette
and Greenberg, 2005). Because P. aeruginosa is a motile bacte-
rium, dispersal may commence with the upregulation of motility,
and recent evidence suggests that indeed both rhamnolipid andChemistry & Biology 19, December 21, 2012 ªtype IV pili are involved in P. aeruginosa
biofilm dispersal (Pamp and Tolker-
Nielsen, 2007). Notably, although the
general principle of biofilm maturation
and dispersal thus appears to be con-
served among phylogenetically distinct
bacteria, the surfactants differ in their
chemical nature, indicating convergentevolution. Interestingly, both PSMs and rhamnolipid have addi-
tional functions in the killing of neutrophils, a key mechanism of
immune evasion, especially in the case of S. aureus (Jensen
et al., 2007; Wang et al., 2007).
During infection, detachment is of the utmost importance
because it may lead to the dissemination of a biofilm-associated
infection. The role of Agr and PSM surfactants in dissemination
was recently demonstrated in animal models of S. aureus
and S. epidermidis catheter-related infection, underscoring the
importance of surfactant-mediated QS control of biofilm-associ-
ated infection (Periasamy et al., 2012; Wang et al., 2011).
Especially in staphylococci, biofilm maturation was also
proposed to occur by enzymatic degradation of biofilm matrix
components, most notably by proteases and nucleases (Boles
and Horswill, 2008; Kiedrowski et al., 2011). However, only
some of these enzymes are under QS control. Importantly, QS
does not regulate production of PIA/PNAG (Vuong et al., 2003),
and PIA/PNAG-degrading enzymes that were found in other
bacteria (Kaplan et al., 2004) are apparently absent from staph-
ylococci. Furthermore, there is no evidence for in vivo relevance
of enzyme-based detachment. In fact, it was recently reported
that nuclease does not contribute to in vivo biofilm dispersal in
S. aureus (Beenken et al., 2012).
In P. aeruginosa, QS appears to regulate Pel exopolysacchar-
ide synthesis, although there are conflicting reports as to how
production is affected (Sakuragi and Kolter, 2007; Ueda and
Wood, 2009). Finally, it should be mentioned that D-amino acids
were shown to trigger biofilm dispersal in the nonpathogenic
Bacillus subtilis (Kolodkin-Gal et al., 2010) and, more recently,
in S. aureus (Hochbaum et al., 2011). However, the underlying
regulated determinants are not known.2012 Elsevier Ltd All rights reserved 1507
Figure 4. QS in P. aeruginosa
P. aeruginosa uses at least three QS systems,
which are arranged in hierarchical order. The rhl
system is under control of the las system, and both
systems use an AHL signal that is produced by the
LasI or RhlI AHL synthetases, respectively. Target
genes are under control of the DNA-binding
regulators LasR, RhlR, and QscR, defining the
respective QS regulons. AHL synthetase genes
are controlled by the corresponding regulator
proteins, resulting in QS-characteristic autofeed-
back loops. The qsc system responds to but does
not produce AHLs. In addition to controlling
production of the qsc system’s target genes, the
QscR DNA-binding protein inhibits expression of
the AHL-producing LasI and RhlI enzymes.
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The first report about the role of QS in bacterial biofilm formation
described the P. aeruginosa Las system as being important for
the formation of structured, extended biofilms, as a lasI mutant
formed an undifferentiated, flat biofilm compared with the wild-
type strain (Davies et al., 1998). Subsequent research in staphy-
lococci underscored the function of QS in biofilm structuring, but
also showed that agrmutants formed a thicker rather than flatter
biofilm compared with the wild-type strains (Vuong et al., 2000,
2003). Also in P. aeruginosa, further investigation of the relation-
ship between QS and biofilm development produced results that
could not be aligned with the initial, simple model of direct, posi-
tive control of biofilm formation by QS (Kirisits and Parsek, 2006).
Similarly, the role of QS in biofilm-associated infection has
remained a complicated issue. In P. aeruginosa, evidence for
a significant role of QS in biofilm-associated CF infection is
based on the detection of QS signals in the sputum of CF
patients (Singh et al., 2000). In S. epidermidis, a contrasting
role for QS in catheter attachment and infiltration of surrounding
tissue was shown (Vuong et al., 2004b). Furthermore, although
QS was reported to have a positive role in many infections, clin-
ical isolates in both staphylococci and P. aeruginosa that were
obtained from chronic biofilm-associated infections were often
demonstrated to be QSmutants, directly arguing against a posi-
tive role for QS in biofilm development (Bjarnsholt et al., 2010;
Traber et al., 2008; Vuong et al., 2004b).
A model that unifies these conflicting results and offers
a possible way to rationalize them is based on distinguishing
two types of virulence, acute and chronic, and recognizing that
QS is important for the expression of acute virulence and the
formation of a differentiated biofilm with the capacity for dissem-
ination, whereas chronic biofilm-associated infection develops
with a downregulation and/or mutation of the QS system(s)
(Figure 5). Reflecting the contrasting bacterial approaches to
infection in cases of high or low QS activity, QS has been1508 Chemistry & Biology 19, December 21, 2012 ª2012 Elsevier Ltd All rights reserveddescribed as a lifestyle determinant of
biofilm-forming pathogenic bacteria.
Accordingly, the determinants of acute
and chronic virulence are regulated by
QS in an opposite fashion. In staphylo-
cocci, toxins and degradative exoen-
zymes as characteristic mediators of
acute virulence are upregulated by QS,whereas nonaggressive colonization and biofilm factors such
as MSCRAMMS are downregulated. Similarly, in P. aeruginosa,
QS upregulates proteases while it downregulates the biofilm
exopolysaccharide alginate. Recent findings provide further
support for this model. In S. aureus, QS mutants are found in
elevated numbers in chronic infection, but these mutants have
lost the ability to infect other individuals, for which active QS is
crucial (Shopsin et al., 2010). In P. aeruginosa, it has been shown
that QSmutants occur in increasing numbers in late stages of CF
infection, whereas rhamnolipid production is maintained in
earlier stages (Bjarnsholt et al., 2010). Finally, cyclic diguanylate
(c-di-GMP), a recently identified regulatory molecule that
governs biofilm formation among many other mechanisms,
was reported to have a key role in regulating ‘‘lifestyle’’ changes
in many biofilm-forming bacteria (Gomelsky and Hoff, 2011;
Hickman et al., 2005). To date, however, there is no in vivo
evidence for a role of c-di-GMP during biofilm infection. Despite
recent insights, an important question remains unanswered:
Does the entire population in chronic biofilms consist of QS
mutants, or are some nonmutant cells reserved to potentially re-
gain the ability to disseminate under changing environmental
conditions? Commonly, clinical microbiology laboratories only
culture one representative isolate from an infection; however,
to answer this question, it will be crucial to analyze amuch higher
number of isolates.
Biofilm Resistance to Antimicrobial Agents and
Mechanisms of Host Defense
Biofilms have a strongly increased capacity to resist antibiotic
treatment and attacks by human host defenses (Costerton
et al., 1999). However, the mechanisms underlying this phenom-
enon are poorly understood. Resistance to antibiotics was re-
ported to involve a series of different mechanisms (Mah and
O’Toole, 2001). First, the biofilmmatrix may represent a diffusion
barrier for antibiotics. Thismay be the case for some but certainly
Figure 5. Role of QS in Biofilm-Associated
Infection
QS systems (such as the staphylococcal Agr
shown here) contribute tomaturation and dispersal
of biofilms. Accordingly, biofilms of an Agr QS
wild-type strain, as shown by CLSM in the middle,
contain channels between cellular agglomera-
tions. Active expression of the QS system (as
shown on the top right in green, using an agr
promoter gfp fusion construct) leads to dispersal.
During prolonged chronic infection, the QS system
in biofilms cells may be irreversibly inactivated by
mutation, leading to excessive growth of compact
biofilms that likely have lost the capacity to
disperse and disseminate. The phenotype of
a surfactant mutant in which all psm genes
controlled by Agr have been inactivated (bottom
right) has the same phenotype as the agr QS
mutant (bottom left), underlining the importance of
surfactants in QS-mediated control of biofilm
maturation and detachment.
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Reviewnot all antibiotics, and appears to be dependent on their physico-
chemical characteristics. Second, biofilm cells have a different
physiological status compared with actively growing, planktonic
cells, which minimizes their sensitivity to antibiotics that target
active cell processes. Third, expression of specific protective
molecules may be higher in the biofilmmode of growth, and anti-
biotics may even directly promote the expression of protective
mechanisms. All of these mechanisms certainly contribute to
biofilm resistance to antibiotics in vitro, but whether any of
them matter in vivo remains unknown.
A hallmark of chronic infections is the incapacity of the
acquired immune system to clear the infection. In the case of
biofilms, this is believed to be mostly due to the shielding of
recognizable epitopes by lowly immunogenic matrix compo-
nents. Whether the mechanisms of innate host defense may
efficiently attack bacteria in established biofilms is poorly under-
stood. The most important innate host defense mechanism is
the elimination of bacteria by professional phagocytes. Activa-
tion of these immune cells depends on the recognition of path-
ogen-associated molecular patterns, but these may also be
hidden by matrix components that do not themselves trigger
phagocyte activation efficiently. The notion that phagocytes
are prevented from infiltrating into a biofilm is controversial
(Leid et al., 2002). However, it is certainly imaginable that the
biofilm matrix provides at least some protection from phagocyte
intrusion, as was postulated early (Krieg et al., 1988; Vaudaux
et al., 1985).
Antibiofilm Therapy
Finding a cure for biofilm infection is one of the most difficult and
challenging tasks in antibacterial drug development. Clearly,
there has not been much success yet. This is because there
are significant problems associated with all approaches that
have been undertaken or conceived to develop antibiofilm
therapeutics.
Theoretically, biofilm formation on indwelling medical devices
can be prevented by altering the device’s surface to prevent
bacterial attachment, or by including antibacterial therapeutics
in the device to prevent early stages of biofilm formation. Inves-
tigators have achieved some limited success using theseChemistry & Biology 1approaches (Rodrigues, 2011), but the fact that biofilms develop
on human matrix proteins rather than directly on the device’s
surface poses a significant problem for this strategy.
Another approach consists of targeting bacterial biofilm deter-
minants. However, it is now clear that different bacteria use
chemically different molecules to establish biofilms. Thus, there
is a great problem with marketability, even if such an approach
could succeed, because only specific bacteria could be tar-
geted. Additionally, one would have to consider that other
microbes might take the place of the targeted biofilm formers
after they are eliminated.
Are there conserved mechanisms of biofilm formation that
may represent the basis for a more broadly applicable biofilm
therapeutic? The most frequently proposed such mechanism is
QS. However, QS systems are conserved more in Gram-nega-
tive than in Gram-positive bacteria. Moreover, the more recent
differentiated view of the role of QS in infection argues strongly
against this approach (Otto, 2004). QS inhibitors such as the
frequently discussed acyl homoserine lactone (AHL) system-
targeting furanones (Hentzer et al., 2002) or inhibitors of the
staphylococcal Agr system (Wright et al., 2005) may have the
potential to reduce toxicity in acute infection, but they appear
to be counterproductive for chronic biofilm-associated infection.
In addition, compounds such as QS inhibitors, which target
virulence expression instead of killing the bacteria, were origi-
nally believed to have a low potential for triggering the develop-
ment of resistance. However, resistance to furanone-based
QS inhibitors was recently reported (Maeda et al., 2012), sug-
gesting the need for a thorough reevaluation of this drug
development strategy.
Targeting biofilm matrix components directly has also been
proposed. For example, the PIA/PNAG exopolysaccharide is
being evaluated as a vaccine target (Maira-Litran et al., 2004).
It was reported that the enzyme dispersin B specifically
degrades PIA/PNAG (Kaplan et al., 2003). The use of a degrada-
tive enzyme may work well in vitro, but it is hard to imagine that it
would work during infection. Finally, the development of antisera
against antigens that are expressed strongly in biofilms has
been proposed (Harro et al., 2010). However, the problem is
less that humans would not be able to produce opsonic9, December 21, 2012 ª2012 Elsevier Ltd All rights reserved 1509
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Reviewantibodies than that the bacteria may be inaccessible for profes-
sional phagocytes.
Unfortunately, an efficient antibiofilm therapeutic is currently
not in sight. This situation calls for intensified molecular research
in the biofilm field, most importantly with a more pronounced
focus on in vivo relevance. In addition, prophylactic prevention
of biofilm formation in hospital settings, such as by increased
hygienic measures, should be emphasized.
Conclusions and Future Outlook
Over the past few decades, many biofilm components and
mechanistic details of biofilm formation and regulation have
been revealed by in vitro research. However, it has also become
clear that different experimental setups often lead to strongly
varying results, and overall, it is difficult to draw conclusions
from in vitro biofilm research with regard to in vivo biofilm-asso-
ciated infection. Even important new concepts in the biofilm
field, such as the contribution of eDNA to biofilm formation,
have not yet been confirmed to have in vivo relevance. To
address this issue, we need to have a stronger focus on (1)
developing and using appropriate animal models of biofilm-
associated infection, and (2) evaluating how clinical samples
from biofilm infections can be obtained and analyzed to provide
more detailed information on in vivo biofilms. For example,
recent advances in genome-wide transcriptomic profiling of
such samples will allow us to gain more detailed insight into
the physiological processes of in vivo biofilms. Furthermore,
especially in the Pseudomonas field, biofilm researchers have
frequently used strains that are characteristic of acute infection
rather than biofilm. The use of such strains should be discontin-
ued in biofilm research except for the analysis of general molec-
ular mechanisms. Biofilm researchers need to reevaluate in vitro
and in vivo experimental approaches thoroughly and determine
which of these approaches will provide a valid representation
of biofilm-associated infection, especially given the urgent
need to develop antibiofilm therapeutics.
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